B. Berger

发表

RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

N. Bressler, S. Bressler, L. Jampol, 2015, Retina.

Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study.

P. Campochiaro, M. Stumpp, U. Fiedler, 2013, American journal of ophthalmology.

Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema

Q. Nguyen, Y. Shildkrot, D. Do, 2019, International Journal of Retina and Vitreous.

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

S. Fauser, J. Sahni, E. Nogoceke, 2020, JAMA ophthalmology.

Vitrectomy for Prevention of Macular Holes: Results of a Randomized Multicenter Clinical Trial

David Williams, S. D. Bustros, M. Maguire, 1994 .

Prostatic carcinoma metastatic to choroid.

J. Dieckert, B. Berger, Brian B. Berger, 1982, The British journal of ophthalmology.

Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome.

B. Glasgow, R. Eagle, D. Boyer, 1988, American journal of ophthalmology.

Endophthalmitis complicating neonatal group B streptococcal septicemia.

B. Berger, 1981, American journal of ophthalmology.

A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.

V. Gonzalez, J. Wells, B. Berger, 2018, Ophthalmic surgery, lasers & imaging retina.

An investigational therapy for geographic atrophy in age-related macular degeneration

C. B. Rickman, P. Garzone, John C. Lin, 2014 .

Phase I, Masked, Placebo-Controlled, Single and Multiple Ascending Intravenous Dose Studies Evaluating Systemic and Ocular Safety, Tolerability, and Visual Acuity Effects of RN6G (PF-04382923) in Subjects with Dry, Age-Related Macular Degeneration (ARMD)

K. Liao, P. Garzone, John C. Lin, 2013 .

Bilateral cytomegalovirus panuveitis after high-dose corticosteroid therapy.

C. Vygantas, B. Berger, H. Tessler, 1979, American journal of ophthalmology.

Miliary toxoplasmic retinitis in acquired immunodeficiency syndrome.

W. Freeman, C. Wiley, B. Berger, 1993, Archives of ophthalmology.

Management of varicella zoster virus retinitis in AIDS

Surinder Kumar, L. Jampol, D. Weinberg, 1997, The British journal of ophthalmology.

Foveal photocoagulation from laser iridotomy.

B. Berger, 1984, Ophthalmology.

Anterior segment ischemia in Fuchs' heterochromic cyclitis.

B. Berger, H. Tessler, M. Kottow, 1980, Archives of ophthalmology.

AIDS Management of varicella zoster virus retinitis in Loose and

L. Jampol, D. Weinberg, B. Berger, 1998 .

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Jennifer K. Sun, L. Aiello, N. Bressler, 2015, JAMA.

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema

G. Jaffe, J. Heier, B. Berger, 2021, Translational vision science & technology.

Retinal pigment epithelial detachments in posterior scleritis.

B. Berger, F. Reeser, 1980, American journal of ophthalmology.

A Randomized Phase 2 Study of an Anti-Amyloid β Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration.

P. Rosenfeld, R. Danis, E. Reichel, 2018, Ophthalmology. Retina.

Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography.

N. Bressler, S. Bressler, S. Grover, 2012, Investigative ophthalmology & visual science.

Massive retinal gliosis simulating choroidal melanoma.

G. Peyman, C. Juárez, B. Berger, 1979, Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie.

Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.

C. Regillo, C. Wykoff, B. Berger, 2023, Ophthalmology.

Vitreous loss managed by anterior vitrectomy. Long-term follow-up of 59 cases.

G. Peyman, B. Berger, K. Zweig, 1980, Archives of ophthalmology.

Ranibizumab Injection (Susvimo) Implant Septum Dislodgement in a Patient With Neovascular Age-Related Macular Degeneration.

B. Berger, Fuad Makkouk, Ivana Gunderson, 2022, JAMA ophthalmology.

Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.

Lloyd Paul Aiello, Ronald P Danis, Neil M Bressler, 2007, Ophthalmology.

Implantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography Evaluation

B. Berger, Shamika Gune, J. Nielsen, 2022, Journal of vitreoretinal diseases.

Safety and Tolerability of Intravitreal Carotuximab (DE-122) in Patients With Persistent Exudative Age-Related Macular Degeneration: A Phase I Study

R. Goldberg, V. Gonzalez, Naveed B K Shams, 2021, Translational Vision Science & Technology.

A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema.

R. Schachar, S. Gilbert, D. Girgenti, 2018, Investigative ophthalmology & visual science.

A CCR 2 / 5 Inhibitor , PF-04634817 , Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema

R. Schachar, S. Gilbert, D. Girgenti, 2018 .

Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.

F. Ferris, E. Chew, R. Murphy, 1993, Ophthalmology.